INVEGA is indicated for the treatment of schizophrenia in adolescents 15 years and older, including acute treatment and recurrence prevention.
INVEGA is indicated for the treatment of acute exacerbations of schizoaffective disorder as monotherapy and in combination with antidepressants and/or mood stabilizers (lithium and valproate).